Thus, it has significant in vitro activity against streptococci, methicillinsusceptible staphylococci, enterobacteriaceae including extendedspectrum b. Favourable clinical response comprising cure and improvement occurred in 91% 43 of 47. Four died 9%, 2 of whom were being treated with ertapenem for a current episode of infection. Pdf ertapenem is a parenteral carbapenem licensed for use in adults and children more. While there was an immediate relative level effect 7%, the rate of decline leveled off in.
Invanz ertapenem is an antibiotic thats usually only given in hospital for serious infections. In vitro comparison of ertapenem, meropenem, and imipenem. Ertapenem invanz a new parenteral carbapenem the medical letter 2002. Eravacycline vs ertapenem in complicated intraabdominal.
Properties and potential of ertapenem oxford academic. We compared the activities of the carbapenems ertapenem, meropenem, and imipenem against 180 isolates of rapidly growing mycobacteria rgm and 170 isolates of nocardia using the clinical and laboratory standards institute clsi guidelines. Ertapenem side effects, dosage, interactions drugs. The carbapenem ertapenem is one of several firstline agents recommended by the infectious disease society of america for the empiric treatment of communityacquired intraabdominal infections of mildtomoderate severity. Ertapenem resistance in klebsiella pneumoniae is rare. Medline search from 1975 to 1997 and followup of references. We report on an ertapenemnonsusceptible phenotype among 25 out of 663 3. The aim of this study was to investigate the molecular mechanisms of ertapenem resistance among enterobacteriaceae isolates in a clinical microbiology laboratory at a tertiary university hospital. Carbapenem mic values for the enterobacteriaceae family according to eucast guidelines antibiotic ertapenem.
Jan 24, 2020 ertapenem is an antibiotic that fights bacteria. So according to this study, ertapenem is as effective as meropenem and imipenem is the treatment of esbl e. Pdf the carbapenems are betalactamtype antibiotics with an. Ertapenem binds to penicillin binding proteins pbps located on the bacterial cell wall, in particular pbps 2 and 3, thereby inhibiting the final transpeptidation step in the synthesis of peptidoglycan, an essential component of the bacterial cell wall. The carbapenems imipenem and meropenem are recommended by the. It showed clinical activity in the treatment of obstetric and gynecological infections, skin and soft tissue infections, communityacquired pneumonia, urinary tract infections, and in intra. The authors concluded that ptz is effective in the treatment of utis caused by esblproducing e. Like meropenem, but unlike imipenem, it has a 1betamethyl substituent and does not require protection with an inhibitor of human renal dihydropeptidase i. Older carbapenems, such as imipenem, were often susceptible to degradation by the enzyme dehydropeptidase1 dhp1 located in renal tubules and required coadministration with a dhp1 inhibitor such as cilastatin.
This was an international, multicenter, openlabel, parallel group, randomized clinical trial of piperacillintazobactam vs meropenem for the definitive treatment of bsi caused by ceftriaxonenonsusceptible e coli or klebsiella spp. Later additions to the class such as meropenem, ertapenem and doripenem. Anaerobic coverage 1,2 all carbapenems have fairly good coverage against anaerobes. Feb 05, 2007 the purpose of this study was to examine the in vivo efficacies of meropenem and ertapenem against extendedspectrum.
We conducted a prospective, randomized, openlabel comparison of the therapeutic efficacy of piperacillintazobactam ptz, cefepime, and ertapenem in febrile nosocomial urinary tract infection with esblproducing escherichia coli esblec. Compare ampicillin vs ertapenem comprehensive analysis by. It is also used to prevent infection in people having certain types of surgery. To compare and contrast imipenem and meropenem in terms of in vitro activity, pharmacokinetics, clinical efficacy and adverse effects. Ertapenem is extensively protein bound at 92% to 95%, followed by imipenemcilastatin at 20%, doripenem 8. Ertapenem is stable against hydrolysis by a variety of betalactamases, including penicillinases, cephalosporinases and extendedspectrum betalactamases. Curiously, the mic distribution of ertapenem for p. The outcome of treating esbl infections with carbapenems vs. Later additions to the class such as meropenem, ertapenem and. In addition, there is also scarcity of reports concerning the clinical. Ertapenem is a new carbapenem developed to address the pharmacokinetic shortcomings short halflife of imipenem and meropenem.
Ertapenem may also be used for purposes not listed in this medication guide. The mean ertapenem dot1,000 apds declined by approximately 68% compared to the preasi phase i 14. Imipenem, meropenem and doripenem have in vivo half lives of approximately 1 hour, while ertapenem has a halflife of approximately 4 hours making it. Meropenem and ertapenem are much more stable to dhp1 due to the insertion of. Otherwise, like imipenem and meropenem, ertapenem has a trans hydroxyethyl.
In this phase iii trial comparing eravacycline with ertapenem for complicated intraabdominal infections, eravacycline met both the fda and ema primary end points of noninferior clinical efficacy vs ertapenem. So far, only three carbapenems, imipenem, meropenem and ertapenem, have. Its antimicrobial spectrum more closely resembles those of meropenem and imipenem than that of ertapenem. Compare ertapenem vs meropenem comprehensive analysis by. Carbapenems are a class of highly effective antibiotic agents commonly used for the treatment. Median length of hospitalisation was 28 days range, 11 to 292. Meropenem is fdaapproved for the treatment of the following infections due to susceptible grampositive, gramnegative, and anaerobic organisms. We included randomized controlled trials rcts comparing different carbapenems vs tgc for the treatment of ciais. Carbapenems vs tigecycline for the treatment of complicated. When administered intravenously, invanz should be infused over a period of 30 minutes. Ertapenem injection route description and brand names. Bactericidal activities of meropenem and ertapenem against.
We use meropenem or imipenem for most esbl infections. Resistant to any carbapenem including doripenem, ertapenem, imipenem or meropenem minimum inhibitory concentrations of. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Ertapenem definition of ertapenem by the free dictionary. Ertapenem resistance has been reported in klebsiella pneumoniaeproducing ctxmtype esbls that have a permeability defect 3,4,14. The ertapenem free drug concentrationtime profile was derived from the work of musson et al. Ertapenem resistance of escherichia coli mariefrederique lartigue, laurent poirel, claire poyart, helene reglierpoupet, and patrice nordmann an ertapenem resistant escherichia coliisolate was recovered from peritoneal fluid in a patient who had been treated with imipenemcilastatin for 10 days. Ertapenem may be preferred over imipenem or meropenem because of its lower cost, feasibility for outpatient intramuscular therapy, and potential value for reducing carbapenem resistance in acinetobacter baumannii a.
Ertapenem is used alone or in combination with other antibiotics to treat infections caused by bacteria in many different parts of the body. The carbapenem antibiotics imipenem, meropenem, ertapenem, and doripenem have a broad antimicrobial spectrum, 199 with activity against almost all aerobic and anaerobic pathogens, although enterococcus faecium are resistant. Doripenem is a new parenteral antibiotic from the carbapenem class. Humansimulated dosing regimens in mice were designed to approximate the free drug percent time above the mic f tmic observed for humans following meropenem at. Imipenem and meropenem carbapenems are broad spectrum betalactam antibiotics that cause bacterial death by weakening the cell wall.
Piperacillintazobactam vs carbapenems for patients with. Listing a study does not mean it has been evaluated by the u. These antibiotics are indicated to treat mixed infections, including aerobic and anaerobic bacteria. The carbapenem antibiotic disks used for each isolate were ertapenem 10mg, imipenem 10mg, meropenem 10mg and doripenem 10mg. For in vivo analysis, commercially available meropenem and ertapenem for injection were obtained. Pubmed, embase, medline via ovid sp and cochrane library databases were systematically searched. It can be given at home, but youll have to be taught how to inject it correctly. It is very important to note here that the small number of patients included and the fact that this is a retrospective study are important limitations to generalize the results.
The most important features of meropenem include enhanced stability toward dhpi, good solubility allowing bolus injection, and good tolerability. These isolates were resistant to carbapenems, with a minimum inhibitory concentration mic greater than or equal to 2 microgml for imipenem or meropenem and an mic greater than or equal to 1 microgml for ertapenem. Ertapenem invanz is a carbapenem and betalactam antibiotic that interferes with bacterial cell wall synthesis in susceptible pathogens. Compare headtohead ratings, side effects, warnings, dosages, interactions and. Invanz ertapenem dose, indications, adverse effects. The purpose of this study was to examine the in vivo efficacies of meropenem and ertapenem against extendedspectrum. The rate of susceptibility to ertapenem and meropenem was limited and less than that to.
Isolates should be accompanied by a public health laboratories phl microbiology submission. Because of that, they were screened for carbapenemase production by testing commercially available disks containing carbapenems with and without edta 0. Properties and potential of ertapenem oxford academic journals. The clinical efficacy and safety of ertapenem for the. Agents with antipseudomonal activity, including doripenem, imipenem, and meropenem are not recommended in this population. Ertapenem is used to treat severe infections of the skin, lungs, stomach, pelvis, and urinary tract. Parenteral ertapenem contains approximately 7 mg 6. The pooled odds ratio or with 95% credible interval cri was calculated by markov. Doripenem vs meropenem against pseudomonas and acinetobacter. May 24, 2019 this feature is not available right now. The rate of susceptibility to ertapenem and meropenem was limited and less than that to imipenem for the. Later additions to the class such as meropenem, ertapenem and doripenem demonstrated increased stability to dhp1. Ertapenem susceptibility was confirmed by the broth microdilution. Ertapenem shares similar structural features with meropenem.
Impact of an antimicrobial stewardship initiative on. Ertapenem was then assayed by a microbiological method to avoid the necessity of extraction, and thereby obtaining the needed sensitivity, using escherichia coli as test organism and following the general procedure described previously 16 lowest limit of detection. Reserve use whenever possible, as it is one of our lastline antibiotics. Randomized controlled trial of piperacillintazobactam. This medicine will not work for colds, flu, or other virus infections. Substitutes and alternatives to invanz ertapenem for uses like colorectal surgical site infection prophylaxis, community acquired pneumonia and diabetic foot infection without osteomyelitis. The patients entered in this trial were somewhat different from those in 2 trials performed in 2015 and 2016. Merrem meropenem is an antibiotic thats usually only given in the hospital for serious infections.
Mechanisms of ertapenem resistance in enterobacteriaceae. The drug is a new carbapenem, similar to imipenem and meropenem that was approved by the fda for once daily iv treatment of intraabdominal, urinary tract, soft tissue, and acute pelvic infections and communityacquired pneumonia. Effect of piperacillintazobactam vs meropenem on 30day. Following a 1g dose of ertapenem administered intravenously, the total and free. Regarding clinical and microbiological success of ptz versus ertapenem, the former reached 93. The pooled odds ratio or with 95% credible interval cri was calculated by. Ertapenem is an acceptable option in the absence of resistance or severe. The rate of susceptibility to ertapenem and meropenem was limited and less than that to imipenem for the rgm. These isolates originated from six different hospitals and were multiclonal, belonging to 12 different genetic clones. A total of 40 clinical isolates including 20 resistant and 20 intermediate isolates were collected from august 2012 to july 20. It is now online, has been for several years, and is now offered free. Compare ampicillin vs ertapenem comprehensive analysis.
It works by killing bacteria or preventing their growth. The sodium content should be considered in patients with conditions that may require sodium restriction, such as congestive heart failure, hypertension, and fluid retention. Carbapenemresistant enterobacteriaceae reporting and. Later additions to the class such as meropenem, ertapenem and doripenem demonstrated increased. Ertapenem, like imipenem and meropenem, demonstrates. Ertapenem, like imipenem and meropenem, demonstrates broadspectrum. This finding may be clinically relevant because ertapenem. Nov 09, 2018 ertapenem is an antibiotic that fights bacteria. Comparison of in vitro efficacy of ertapenem, imipenem and. Compared with imipenem, meropenem and doripenem, the spectrum of activity of ertapenem is more limited primarily because it lacks activity against pseudomonas aeruginosa and enterococcus spp. Due to limited therapeutic options, the spread of extendedspectrum betalactamases esbls have become a major public health concern. Susceptibility to the group 2 carbapenems, imipenem and meropenem. Meropenem is slightly more active than imipenem against gramnegative bacilli and slightly less active against gram.
1447 796 653 1126 1117 251 398 372 1141 1086 278 682 194 703 1547 241 371 1632 1542 92 404 477 1632 1119 130 230 356 1061 1421 139 917 270